Home » Topics » BioWorld Science

BioWorld Science
RSS

Sinovent presents new E-NPP 2 inhibitors

Sep. 6, 2019

European Commission approves Tecentriq for extensive-stage SCLC and non-squamous NSCLC

Sep. 6, 2019

Merck & Co. describes HIV integrase inhibitors

Sep. 6, 2019

Medshine Discovery divulges FGFR inhibitors

Sep. 6, 2019

A novel preclinical model of cocaine and alcohol coabuse

Sep. 6, 2019

Discovery of indazole/indole derivatives acting as glucagon receptor antagonists

Sep. 6, 2019

Zika vaccine averts dengue cross-reactive antibody responses

Sep. 6, 2019

Acesion presents data on the selective negative allosteric SK channel modulator AP-30663

Sep. 6, 2019

New AAV gene therapy for mucopolysaccharidosis IVA

Sep. 6, 2019

Bristol-Myers Squibb describes preclinical profile of apelin receptor agonist BMS-986224

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...